HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients.

Introduction. There is an association between HCV and insulin resistance (IR), which is currently assessed by HOMA-IR. There is evidence that HOMA-adiponectin (HOMA-AD) is more accurate, but its role in HCV patients is unknown.